Search

Your search keyword '"Perren, T"' showing total 318 results

Search Constraints

Start Over You searched for: Author "Perren, T" Remove constraint Author: "Perren, T"
318 results on '"Perren, T"'

Search Results

51. Paclitaxel plus carboplatin versus standard chemotherapy with either single-agent carboplatin or cyclophosphamide, doxorubicin, and cisplatin in women with ovarian cancer: The ICON3 randomised trial

58. ChlVPP combination chemotherapy for Hodgkin's disease: long-term results

61. Conventional Adjuvant Chemotherapy Versus Single-Cycle, Autograft-Supported, High-Dose, Late-Intensification Chemotherapy in High-Risk Breast Cancer Patients: A Randomized Trial

64. Ovarian ablation (OA) in pre-menopausal women with early breast cancer prescribed 5 years tamoxifen (T) or T plus chemotherapy (CT)–results from the UK NCRI Adjuvant Breast Cancer (ABC) international trial of 2,144 patients

73. Positive and negative selection to reduce tumour contamination in peripheral blood stem cell harvests

79. Randomized trial assessing the addition of interferon alpha-2a to fluorouracil and leucovorin in advanced colorectal cancer. Colorectal Cancer Working Party of the United Kingdom Medical Research Council.

84. Management of breast cancer Refer women to multidisciplinary breast clinics

88. A prospective randomised phase II trial of thalidomide with carboplatin compared with carboplatin alone as a first-line therapy in women with ovarian cancer, with evaluation of potential surrogate markers of angiogenesis.

90. Timing of breast cancer surgery in relation to menstrual cycle phase: no effect on 3-year prognosis: The ITS Study.

94. Snowboarder's talus fracture: treatment outcome of 20 cases after 3.5 years.

95. Phase II Study of Zoladex Depot in Advanced Prostatic Cancer with Special Reference to Criteria of Response and Survival.

97. Treatment of relapsed and refractory acute leukaemia with high-dose cytosine arabinoside and etoposide.

98. A new approach to the treatment of advanced high-grade non-Hodgkin's lymphoma--intensive two-phase chemotherapy.

99. Pharmacokinetic and endocrinological parameters of a slow-release depot preparation of the GnRH analogue ICI 118630 (zoladex) compared with a subcutaneous bolus and continuous subcutaneous infusion of the same drug in patients with prostatic cancer.

Catalog

Books, media, physical & digital resources